We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$641M
Cap. Flow
+$372M
Cap. Flow %
16.15%
Top 10 Hldgs %
31.4%
Holding
680
New
190
Increased
323
Reduced
69
Closed
28

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.6M
2
AOS icon
A.O. Smith
AOS
+$7.79M
3
JPM icon
JPMorgan Chase
JPM
+$7.71M
4
MSFT icon
Microsoft
MSFT
+$6.58M
5
BAC icon
Bank of America
BAC
+$6.05M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.15M
2
MD icon
Pediatrix Medical
MD
+$3.07M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$2.05M
4
W icon
Wayfair
W
+$1.83M
5
ARWR icon
Arrowhead Research
ARWR
+$1.69M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 15.48%
3 Consumer Discretionary 11.83%
4 Financials 11.36%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASMB icon
626
Assembly Biosciences
ASMB
$529M
$57K ﹤0.01%
242
-177
-42% -$44.8K
IRM icon
627
Iron Mountain
IRM
$36.1B
$55K ﹤0.01%
1,548
– –
SNDX icon
628
Syndax Pharmaceuticals
SNDX
$1.82B
$55K ﹤0.01%
10,419
-2,244
-18% -$12.8K
MAA icon
629
Mid-America Apartment Communities
MAA
$15.7B
$53K ﹤0.01%
485
– –
COTY icon
630
Coty
COTY
$2.48B
$50K ﹤0.01%
4,359
-4,418
-50% -$41.8K
AIV
631
Aimco
AIV
$383M
$49K ﹤0.01%
7,342
+15
+0.2% +$97
SLG icon
632
SL Green Realty
SLG
$3.99B
$48K ﹤0.01%
557
– –
BMRN icon
633
BioMarin Pharmaceuticals
BMRN
$12.4B
$45K ﹤0.01%
+506
New +$46.9K
IOVA icon
634
Iovance Biotherapeutics
IOVA
$2.87B
$45K ﹤0.01%
4,758
-510
-10% -$4.95K
CLDR
635
DELISTED
Cloudera, Inc.
CLDR
$45K ﹤0.01%
4,101
+151
+4% +$1.94K
TRIP icon
636
TripAdvisor
TRIP
$1.26B
$44K ﹤0.01%
861
+95
+12% +$5.21K
TBPH icon
637
Theravance Biopharma
TBPH
$877M
$35K ﹤0.01%
1,542
– –
BPY
638
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$34K ﹤0.01%
1,656
– –
KIM icon
639
Kimco Realty
KIM
$16.4B
$32K ﹤0.01%
1,716
– –
ALNA
640
DELISTED
Allena Pharmaceuticals
ALNA
$32K ﹤0.01%
4,546
+132
+3% +$957
MAC icon
641
Macerich
MAC
$6.92B
$31K ﹤0.01%
726
– –
MDGL icon
642
Madrigal Pharmaceuticals
MDGL
$11.8B
$31K ﹤0.01%
250
– –
CVET
643
DELISTED
Covetrus, Inc. Common Stock
CVET
$29K ﹤0.01%
+905
New +$32.1K
CRNX icon
644
Crinetics Pharmaceuticals
CRNX
$8.92B
$27K ﹤0.01%
+1,208
New +$29.7K
WBD icon
645
Warner Bros
WBD
$67.1B
$24K ﹤0.01%
911
+161
+21% +$4.48K
CHMA
646
DELISTED
Chiasma, Inc. Common Stock
CHMA
$24K ﹤0.01%
+4,700
New +$20.7K
NWS icon
647
News Corp Class B
NWS
$17.5B
$21K ﹤0.01%
1,668
+306
+22% +$3.9K
XLB icon
648
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$20K ﹤0.01%
710
– –
DISCK
649
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$18K ﹤0.01%
711
-1,516
-68% -$39.6K
XBI icon
650
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$10K ﹤0.01%
+115
New +$9.78K
24 25
26
27 28

Similar funds

TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return

Tiverton Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Tiverton Asset Management held 680 positions worth $2.31B, up 38% from $1.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tiverton Asset Management deployed $372M of net new capital in Q1 2019, opening 190 new positions and adding to 323 existing holdings. Its largest new stake was Pfizer: 104,318 shares worth $4.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Celgene Corp, an estimated $7.15M trimmed.

  • Tiverton Asset Management's largest Q1 2019 buy was Pfizer: 104,318 shares worth $4.2M.
  • Tiverton Asset Management added most to Alphabet (Google) Class A in Q1 2019, an estimated $9.6M increase.
  • Tiverton Asset Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $7.15M.
  • Tiverton Asset Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $1.07M.
  • Tiverton Asset Management's ten largest holdings make up 31% of its $2.31B portfolio in Q1 2019.
  • Tiverton Asset Management opened 190 new positions and closed 28 in Q1 2019.
  • Tiverton Asset Management's portfolio value rose 38% quarter-over-quarter to $2.31B.

Based on Tiverton Asset Management's 13F filing for Q1 2019, filed 13 May 2019.